Pt(II) squares as selective and effective human telomeric G-quadruplex binders and potential cancer therapeutics

Dalton Trans. 2012 Oct 14;41(38):11807-12. doi: 10.1039/c2dt31303k. Epub 2012 Aug 20.

Abstract

A series of four self-assembled Pt(II) molecular squares with 4,4'-dipyridyl or pyrazine bridges, including the previously reported Pt(II) squares [Pt(en)(4,4'-dipyridyl)](4)(NO(3))(8) (1), were investigated for their abilities to act as selective and effective human telomeric (htelo) G-quadruplex binders. FRET and SPR studies demonstrated that Pt(II) squares could discriminate against duplex DNA, and show promising selectivity between intramolecular G-quadruplexes. PCR-stop assays and CD studies showed that Pt(II) squares strongly induced the formation of parallel G-quadruplexes. ITC experiments indicated that Pt(II) squares could bind to the G-quadruplex with high binding constants (K(b) values ranging from 10(4)-10(8) M(-1)). All four Pt(II) squares were effective inhibitors of human telomerase, and showed anticancer efficacy. This was particularly the case for [Pt(NH(3))(2)(4,4'-dipyridyl)](4)(NO(3))(8) (2), which exhibited a 15-fold higher antiproliferative effect on A549/cisR cells than cisplatin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents / toxicity
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Circular Dichroism
  • Coordination Complexes / chemistry*
  • Coordination Complexes / therapeutic use
  • Coordination Complexes / toxicity
  • G-Quadruplexes*
  • Humans
  • Neoplasms / drug therapy
  • Organoplatinum Compounds / chemistry*
  • Organoplatinum Compounds / therapeutic use
  • Organoplatinum Compounds / toxicity
  • Platinum / chemistry*
  • Telomerase / antagonists & inhibitors
  • Telomerase / metabolism
  • Thermodynamics

Substances

  • Antineoplastic Agents
  • Coordination Complexes
  • Organoplatinum Compounds
  • Platinum
  • Telomerase